NASDAQ:CARA   Cara Therapeutics, Inc
Entry price: 19.86

Fundamentals:

- Sector: Medical - Biotech

- EPS % Chg (Last Qtr): 52%

- EPS % Chg (Previous Qtr): 7%

- 3 Year EPS Growth Rate: 0%

- EPS Est % Chg (Current Yr): 0%

- Sales % Chg (Last Qtr): 60%

- Sales % Chg (Previous Qtr): 8%

- 3-Year Sales Growth Rate: 113%

- Annual Pre -Tax Margin: -539%
Comment:
Comment: ________________________
- EPS % Chg (Last Qtr): 360%
- Sales % Chg (Last Qtr): 2391%